As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

DNA-testing company 23andMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at the factors that have ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Elliott Management has accumulated a $5bn stake in industrial conglomerate Honeywell International, in one of the US activist ...